Dr. Thurston and Dr. Maki's study focused on late perimenopausal and postmenopausal women with hot flashes (vasomotor symptoms, VMS) and their association with Alzheimer's biomarkers.
Nighttime VMS were linked to a significantly lower amyloid beta 42tobeta 40 ratio, raising concerns about Alzheimer's disease risk.
Studies suggest menopausal hormone therapy could positively impact Alzheimer's biomarkers, reducing the disease's incidence.
Reducing nighttime hot flashes, potentially through hormone therapy, could lower Alzheimer's disease risk in high-risk women.
[
add
]
[
|
|
...
]